Literature DB >> 29686568

Significance of green granules in neutrophils and monocytes.

Tina Gorup1, Andrea T Cohen1, Amelia B Sybenga2, Edward S Rappaport1,2.   

Abstract

Intracytoplasmic green granules in neutrophils have been the subject of conjecture and discussion. Sometimes nicknamed "death cells," these granules are often associated with severe liver disease and have been said to predict acute bad outcomes in severely ill patients. Some recommend that the laboratory community report these granules to treating clinicians as an indication of poor prognosis. We report two patients presenting with secondary liver disease who were found to have blue-green neutrophilic inclusions on the peripheral blood smear. One patient died, while the other patient recovered. We propose that this morphologic finding is likely transient and is related to liver disease and that recovery is possible. Additionally, prognosis in intensive care units continues to be determined by a number of variables, such as age, comorbidities, and severity of illness.

Entities:  

Keywords:  Granules; WBC granules; WBC inclusions; green granules

Year:  2017        PMID: 29686568      PMCID: PMC5903543          DOI: 10.1080/08998280.2017.1391045

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  8 in total

1.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis
Journal:  Circulation       Date:  2012-08-24       Impact factor: 29.690

2.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

3.  The origin of thrombolytic therapy.

Authors:  S Sherry
Journal:  J Am Coll Cardiol       Date:  1989-10       Impact factor: 24.094

4.  Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial.

Authors:  Marc S Sabatine; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon
Journal:  Am Heart J       Date:  2005-02       Impact factor: 4.749

5.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.

Authors:  Marc S Sabatine; Christopher P Cannon; C Michael Gibson; Jose L López-Sendón; Gilles Montalescot; Pierre Theroux; Marc J Claeys; Frank Cools; Karen A Hill; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-03-09       Impact factor: 91.245

6.  Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.

Authors:  R Collins; S MacMahon; M Flather; C Baigent; L Remvig; S Mortensen; P Appleby; J Godwin; S Yusuf; R Peto
Journal:  BMJ       Date:  1996-09-14

Review 7.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

Review 8.  Cardiovascular disease and bridging the diagnostic gap.

Authors:  John Kelly Wachira; Tom P Stys
Journal:  S D Med       Date:  2013-09
  8 in total
  2 in total

1.  Critical blue-green inclusions in neutrophil and monocyte cytoplasm in a healthy patient affected by COVID-19.

Authors:  Guilherme Dienstmann; Samuel Ricardo Comar; Matheus Leite Ramos de Souza; Graziela Ruaro; Luiz Arthur Calheiros Leite
Journal:  Hematol Transfus Cell Ther       Date:  2020-07-24

2.  Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients.

Authors:  Miguel D Cantu; William S Towne; Foxwell N Emmons; Maria Mostyka; Alain Borczuk; Steven P Salvatore; He S Yang; Zhen Zhao; Ljiljana V Vasovic; Sabrina E Racine-Brzostek
Journal:  Br J Haematol       Date:  2020-06-13       Impact factor: 8.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.